Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-05-21

Clinical Trial Update: Treatment of Recurrent Hepatitis C After Liver Transplantation [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating treatment for recurrent Hepatitis C after liver transplantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Rennes University Hospital | Conditions: Liver Transplantation, Hepatitis C | Phase 3 | Status: COMPLETED